Search

everythinglearnresearchcommunity

for

Search:↓

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

People with hidradenitis suppurativa have a higher risk of heart attacks and strokes.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Myrtle has various health benefits and potential for medicine development.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Oral testosterone therapy raises heart risk more than other methods.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

miR-218-5p helps skin and hair growth by targeting SFRP2 and activating a specific signaling pathway.